Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM).

Mohd Rozaini RosliDavid Bin-Chia WuChin Fen Neoh Mahmathi Karuppannan

Published in: Journal of medical economics (2021)

HMR-CP was a cost-effective intervention that had significantly reduced the HbA1c among the T2DM patients, although associated with higher mean total costs per participant.

Keyphrases

end stage renal disease
healthcare
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
randomized controlled trial
peritoneal dialysis
emergency department
mental health
primary care
adipose tissue
type diabetes
insulin resistance